Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 5, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zivo Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 3
| |||||||
Zivo Bioscience, Inc.
| 57 |
$2.50 | $142.50 | +0.61% | 9.4K |
Dec 19
| |||||||
Zivo Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 16
| |||||||
Zivo Bioscience, Inc.
| 9.17K |
$2.50 | $22,920.00 | +5,209.09% | 9.34K |
Jan 25 - Jan 27
| |||||||
Zivo Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 21
| |||||||
Zivo Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 12
| |||||||
Zivo Bioscience, Inc.
| 14.15K |
$0.11 | -$943.39 |
∞
| 14.15K |
Sep 9 - Sep 30
| |||||||
Zivo Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 10 - Sep 26
| |||||||
Nexvet Biopharma Plc
| -17.00K |
$6.72 | -$114,206.40 | -100.00% |
0
|
Jul 31
| |||||||
Nexvet Biopharma Plc
| 3.6K |
$0.13 | $450.00 | +50.00% | 10.8K |
Jul 1
| |||||||
Nexvet Biopharma Plc
|
0
|
—
|
—
|
—
|
0
|
Sep 5
| |||||||
Nexvet Biopharma Plc
| 3.6K |
$0.13 | $450.00 | +100.00% | 7.2K |
Jul 1
| |||||||
Nexvet Biopharma Plc
| 3.6K |
$0.13 | $450.00 |
∞
| 3.6K |
Jul 1
| |||||||
Nexvet Biopharma Plc
|
0
|
—
|
—
|
—
|
0
|
Sep 3
| |||||||
Nexvet Biopharma Plc
| 900 |
$0.13 | $112.50 | +33.33% | 3.6K |
Jun 30
| |||||||
Nexvet Biopharma Plc
| 900 |
$0.13 | $112.50 | +50.00% | 2.7K |
May 18
| |||||||
Nexvet Biopharma Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Health Enhancement Products Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |